drugset / Trial / NCT00597675
Oral Immunotherapy for Peanut Allergy (PMIT)
Phase 2
Completed
10 enrolled
University of North Carolina, Chapel Hill
University of Arkansas · collab
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to determine if mucosal peanut immunotherapy will make subjects who have peanut allergy less allergic and induce changes in their immune system.
Timeline
- Start
- 2007-03
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Defatted peanut flour | Unknown | 4 g | Oral |